H2AX and cancer: As shown in SI Appendix, Fig. S9A, the treatment of cancer cells with a low dose of Nutlin-3 resulted in a more rapid decrease in γ-H2AX levels, demonstrating that p53 activation indeed promotes the repair of DNA damage caused by Cisplatin.